Aug 1, 2024, 15:35
Harold Burstein: Thoughtful op-ed on multicancer ctDNA genomic screens by Hilary Robbins
Harold Burstein, Breast cancer specialist and Professor at Dana Farber Cancer Institute, shared a post on X about a recent paper by Hilary Robbins titled “Multicancer Early Detection Tests — Keeping a High Bar for Evidence of Benefit” published in The New England Journal of Medicine.
“Thoughtful op-ed on multicancer ctDNA genomic screens. Issues of false-reassurance, and on other side, positives without clinical cancers, are important to address.”
Source: Harold Burstein/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46